Publication: Stability and reproducibility of proteomic profiles measured with an aptamer-based platform
Open/View Files
Date
2018
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Nature Publishing Group UK
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Kim, Claire H., Shelley S. Tworoger, Meir J. Stampfer, Simon T. Dillon, Xuesong Gu, Sherilyn J. Sawyer, Andrew T. Chan, Towia A. Libermann, and A. Heather Eliassen. 2018. “Stability and reproducibility of proteomic profiles measured with an aptamer-based platform.” Scientific Reports 8 (1): 8382. doi:10.1038/s41598-018-26640-w. http://dx.doi.org/10.1038/s41598-018-26640-w.
Research Data
Abstract
The feasibility of SOMAscan, a multiplex, high sensitivity proteomics platform, for use in studies using archived plasma samples has not yet been assessed. We quantified 1,305 proteins from plasma samples donated by 16 Nurses’ Health Study (NHS) participants, 40 NHSII participants, and 12 local volunteers. We assessed assay reproducibility using coefficients of variation (CV) from duplicate samples and intra-class correlation coefficients (ICC) and Spearman correlation coefficients (r) of samples processed (i.e., centrifuged and aliquoted into separate components) immediately, 24, and 48 hours after collection, as well as those of samples collected from the same individuals 1 year apart. CVs were <20% for 99% of proteins overall and <10% for 92% of proteins in heparin samples compared to 66% for EDTA samples. We observed ICC or Spearman r (comparing immediate vs. 24-hour delayed processing) ≥0.75 for 61% of proteins, with some variation by anticoagulant (56% for heparin and 70% for EDTA) and protein class (ranging from 49% among kinases to 83% among hormones). Within-person stability over 1 year was good (ICC or Spearman r ≥ 0.4) for 91% of proteins. These results demonstrate the feasibility of SOMAscan for analyses of archived plasma samples.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service